Ubs Oconnor LLC Aclaris Therapeutics, Inc. Transaction History

Ubs Oconnor LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$6.56 - $10.95 $32,800 - $54,750	-5,000 Reduced 6.85%	68,014 $465,000
Q2 2023 Aug 14, 2023	BUY	$7.89 - $10.64 $576,080 - $776,868	73,014 New	73,014 $757 Million
Q1 2023 May 15, 2023	SELL	$7.07 - $17.95 $360,676 - $915,719	-51,015 Reduced 37.88%	83,678 $676,000
Q4 2022 Feb 14, 2023	BUY	$14.33 - $18.37 $304,756 - $390,674	21,267 Added 18.75%	134,693 $0
Q2 2022 Aug 12, 2022	BUY	$10.16 - $17.08 $608,827 - $1.02 Million	59,924 Added 112.0%	113,426 $1.58 Million
Q1 2022 May 16, 2022	BUY	$9.74 - $17.92 $521,109 - $958,755	53,502 New	53,502 $922,000

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $193M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

Stay updated on Ubs Oconnor LLC with notifications on news.